Nassour J, Radford R, Correia A, Fust JM, Schoell B, Jauch A, et al
BMI 27 with weight-related conditions, such as: Type 2 diabetes or prediabetes Hypertension High cholesterol Sleep apnea Fatty liver disease (NAFLD) PCOS Insulin resistance Patients in this range may be candidates because GLP-1 medications act on pathways related to blood sugar, appetite, and metabolic regulation
Complex medical cases: Frequent monitoring needs suit traditional clinics ($450-$700/month) better than telehealth, despite higher costs
Brands can also benefit from altering product lines to appeal to individuals pursuing a weight loss journey
And as you've seen this figure, they start to rise already after BMI 25, and when we cross 30, they are already three times more common
3 Effects of SSRIs on embryonic development Exposure to any SSRIs such as citalopram, paroxetine, and sertraline at any time during pregnancy has been shown to increase the risk of fetal mortality (Figure 2) ( postpartum hemorrhage may also be increased